Feature Cocrystal Pharma advancing programs in high-value antiviral drug targets With a drug discovery technology platform developed by several Nobel Prize laureates, Cocrystal Pharma (NASDAQ:COCP) is advancing broad spectrum antivirals in three programs: coronaviruses and variants, pandemic and... April 5, 2022